PHILADELPHIA, PA — Carisma Therapeutics Inc. (Nasdaq: CARM), a clinical-stage biopharmaceutical company focusing on engineered macrophages, has announced that its President and Chief Executive Officer, Steven Kelly, will participate in a fireside chat at the 6th Annual Evercore ISI HealthCONx Conference. The event is scheduled for Wednesday, November 29 at 2:35 pm ET.
The Evercore ISI HealthCONx Conference is a prestigious event in the healthcare sector, attracting a diverse audience of investors, analysts, and industry professionals. It provides an invaluable platform for companies like Carisma Therapeutics to share their story, discuss their strategies, and engage directly with the investment community.
The fireside chat will be broadcast via an audio webcast, making it accessible not only to those attending the conference but also to members of the news media, investors, and the general public.
Interested parties can access the webcast on the ‘Investor Events’ section of Carisma Therapeutics’ Investor Relations webpage. To ensure that no interested party misses out, the webcast will be archived and available for a limited time following the event.
As investors and market watchers look forward to this presentation, it’s clear that Carisma Therapeutics is a company worth keeping an eye on.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.